[go: up one dir, main page]

NO20015308D0 - En farmasöytisk formulering som inneholder en inhibitor av karboksypeptidase U og A trombininhibitor - Google Patents

En farmasöytisk formulering som inneholder en inhibitor av karboksypeptidase U og A trombininhibitor

Info

Publication number
NO20015308D0
NO20015308D0 NO20015308A NO20015308A NO20015308D0 NO 20015308 D0 NO20015308 D0 NO 20015308D0 NO 20015308 A NO20015308 A NO 20015308A NO 20015308 A NO20015308 A NO 20015308A NO 20015308 D0 NO20015308 D0 NO 20015308D0
Authority
NO
Norway
Prior art keywords
inhibitor
carboxypeptidase
pharmaceutical formulation
formulation containing
thrombin
Prior art date
Application number
NO20015308A
Other languages
English (en)
Other versions
NO20015308L (no
Inventor
Tommy Abrahamsson
Viveca Nerme
Magnus Polla
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE9901573A external-priority patent/SE9901573D0/xx
Priority claimed from SE9901572A external-priority patent/SE9901572D0/xx
Priority claimed from SE9902902A external-priority patent/SE9902902D0/xx
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of NO20015308D0 publication Critical patent/NO20015308D0/no
Publication of NO20015308L publication Critical patent/NO20015308L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/57—Protease inhibitors from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO20015308A 1999-05-03 2001-10-30 En farmasoytisk formulering som inneholder en inhibitor av karboksypeptidase U og A trombininhibitor NO20015308L (no)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
SE9901573A SE9901573D0 (sv) 1999-05-03 1999-05-03 New compounds
SE9901572A SE9901572D0 (sv) 1999-05-03 1999-05-03 New compounds
SE9902902A SE9902902D0 (sv) 1999-08-13 1999-08-13 New formulation
PCT/SE2000/000847 WO2000066152A1 (en) 1999-05-03 2000-05-03 A pharmaceutical formulation containing an inhibitor of carboxypeptidase u and a thrombin inhibitor

Publications (2)

Publication Number Publication Date
NO20015308D0 true NO20015308D0 (no) 2001-10-30
NO20015308L NO20015308L (no) 2001-12-03

Family

ID=27355973

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20015308A NO20015308L (no) 1999-05-03 2001-10-30 En farmasoytisk formulering som inneholder en inhibitor av karboksypeptidase U og A trombininhibitor

Country Status (26)

Country Link
US (1) US6974800B1 (no)
EP (1) EP1181048B1 (no)
JP (1) JP2002543148A (no)
KR (1) KR100725206B1 (no)
CN (1) CN100518820C (no)
AR (1) AR023819A1 (no)
AT (1) ATE447964T1 (no)
AU (1) AU763772B2 (no)
BR (1) BR0010255A (no)
CA (1) CA2371217A1 (no)
CZ (1) CZ20013932A3 (no)
DE (1) DE60043297D1 (no)
EE (1) EE200100578A (no)
ES (1) ES2335383T3 (no)
HK (1) HK1042442B (no)
HU (1) HUP0201615A3 (no)
IL (1) IL145951A0 (no)
IS (1) IS6140A (no)
MX (1) MXPA01011044A (no)
MY (1) MY126962A (no)
NO (1) NO20015308L (no)
NZ (1) NZ515063A (no)
SK (1) SK15652001A3 (no)
TR (1) TR200103151T2 (no)
TW (1) TWI232106B (no)
WO (1) WO2000066152A1 (no)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9901572D0 (sv) * 1999-05-03 1999-05-03 Astra Ab New compounds
ES2202171T3 (es) 1999-09-14 2004-04-01 Meiji Seika Kaisha, Ltd. Derivados del acido fosfonico que poseen actividad inhibidora de la carboxipeptidas b.
SE0001803D0 (sv) 2000-05-16 2000-05-16 Astrazeneca Ab New compounds i
SE0103272D0 (sv) 2001-09-28 2001-09-28 Astrazeneca Ab Chemical compounds
US6713496B2 (en) 2002-01-22 2004-03-30 Pfizer Inc 3-(imidazolyl)-2-alkoxypropanoic acids
JP2005516972A (ja) 2002-01-22 2005-06-09 ファイザー・インク 血栓疾患の治療のためのｔａｆｉ−ａ阻害剤として使用される３−（イミダゾリル）−２−アミノプロピオン酸
AU2003230698B2 (en) 2002-03-21 2009-03-26 Bayer Schering Pharma Aktiengesellschaft Plasma carboxypeptidase B inhibitors
DK1896059T3 (da) * 2005-06-24 2013-04-08 Drugrecure Aps Luftvejsadministration af Tissue Factor Pathway Inhibitor ved inflammatoriske tilstande, der påvirker luftvejene
US9834527B2 (en) 2013-06-10 2017-12-05 Sanofi Macrocyclic urea derivatives as inhibitors of TAFIa, their preparation and their use as pharmaceuticals
EP3569617A1 (en) * 2018-05-18 2019-11-20 Trion Research GmbH Pharmaceutical preparation for use in treating epstein- barr virus positive patients with reactivation phenomenon- associated diseases

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3091569A (en) 1960-08-26 1963-05-28 Mead Johnson & Co Mucolytic-nu-acylated sulfhydryl compositions and process for treating animal mucus
FR1393338A (fr) 1964-01-08 1965-03-26 Rech S Pharma Et Scient Nouveau dérivé de la cystéine et sa préparation
US3766206A (en) 1971-11-03 1973-10-16 Pfizer 18beta-glycyrrheting acid amides useful as antiulcer agents
FR2266502A1 (en) 1974-04-08 1975-10-31 Synpharm Sa N-(2-thenoyl)-cysteine and esters - with mucolytic activity, prepd. from cysteine (esters) and thenoyl chloride
US4113715A (en) 1977-01-17 1978-09-12 E. R. Squibb & Sons, Inc. Amino acid derivatives
US4177277A (en) 1977-01-17 1979-12-04 E. R. Squibb & Sons, Inc. Method for alleviating hypertension
JPS545949A (en) 1977-06-16 1979-01-17 Hisamitsu Pharmaceut Co Inc Novel cyclohexanecarboxylic acid and its derivatives
FR2430945A2 (fr) 1978-07-12 1980-02-08 Chauvin Blache Lab Nouveaux derives de la cysteine, leur procede de fabrication et leur application en therapeutique
US4708965A (en) 1985-09-16 1987-11-24 Morgan Lee R Method of treating herpes virus infections with N,N'-diacetylcystine and derivatives
DE3838467C2 (de) 1988-11-12 1998-12-10 Agfa Gevaert Ag Fotografisches Aufzeichnungsmaterial
US5206161A (en) * 1991-02-01 1993-04-27 Genentech, Inc. Human plasma carboxypeptidase B
IT1249650B (it) 1991-05-29 1995-03-09 Poli Ind Chimica Spa N-(5-tioxo-l-prolil)-l-cisteina e suoi derivati, loro preparazione ed impiego terapeutico
SE9103612D0 (sv) * 1991-12-04 1991-12-04 Astra Ab New peptide derivatives
SE9301916D0 (sv) * 1993-06-03 1993-06-03 Ab Astra New peptides derivatives
SE9404196D0 (sv) * 1994-12-02 1994-12-02 Astra Ab New antithrombotic formulation
KR0173034B1 (ko) 1995-04-28 1999-03-30 성재갑 선택적 트롬빈 억제제
GB9525620D0 (en) * 1995-12-15 1996-02-14 Glaxo Group Ltd Chemical compounds
US5859271A (en) * 1996-04-15 1999-01-12 Virginia Commonwealth University Cytoprotective compounds
US6126939A (en) * 1996-09-03 2000-10-03 Yeda Research And Development Co. Ltd. Anti-inflammatory dipeptide and pharmaceutical composition thereof
US5993815A (en) * 1996-11-08 1999-11-30 University Of Vermont Methods and compositions for inhibiting the activation of thrombin-activatable fibrinolysis inhibitor (TAFI)
US6117911A (en) * 1997-04-11 2000-09-12 Neorx Corporation Compounds and therapies for the prevention of vascular and non-vascular pathologies

Also Published As

Publication number Publication date
CA2371217A1 (en) 2000-11-02
WO2000066152A1 (en) 2000-11-09
ATE447964T1 (de) 2009-11-15
AU763772B2 (en) 2003-07-31
AR023819A1 (es) 2002-09-04
TWI232106B (en) 2005-05-11
EP1181048B1 (en) 2009-11-11
HK1042442A1 (en) 2002-08-16
BR0010255A (pt) 2002-02-13
KR20020003386A (ko) 2002-01-12
CZ20013932A3 (cs) 2002-04-17
DE60043297D1 (de) 2009-12-24
AU4447200A (en) 2000-11-17
CN100518820C (zh) 2009-07-29
CN1350463A (zh) 2002-05-22
EP1181048A1 (en) 2002-02-27
HK1042442B (en) 2010-04-09
MY126962A (en) 2006-11-30
EE200100578A (et) 2003-02-17
IS6140A (is) 2001-11-01
SK15652001A3 (sk) 2002-07-02
KR100725206B1 (ko) 2007-06-07
TR200103151T2 (tr) 2002-04-22
MXPA01011044A (es) 2002-06-04
HUP0201615A2 (en) 2002-09-28
US6974800B1 (en) 2005-12-13
ES2335383T3 (es) 2010-03-26
NO20015308L (no) 2001-12-03
IL145951A0 (en) 2002-07-25
NZ515063A (en) 2003-08-29
HUP0201615A3 (en) 2006-07-28
JP2002543148A (ja) 2002-12-17
PL356119A1 (en) 2004-06-14

Similar Documents

Publication Publication Date Title
ID27394A (id) Kombinasi farmasi yang mengandung inhibitor cox-2 dan inhibitor inos
HUP0201680A3 (en) Aromatic sulfone hydroxamic acid derivatives metalloprotease inhibitors and pharmaceutical compositions containing them
HUP0400206A3 (en) Imidazolidindion derivatives having metalloproteinase inhibitor effect a their use for preparation of pharmaceutical compositions and pharmaceutical compositions containing them
PT1105123E (pt) Composicoes farmaceuticas contendo inibidores da lipase e quitosano
NO20021401D0 (no) Konazolinforbindelser og farmasöytiske preparater inneholdende slike forbindelser
PT1306082E (pt) Inaladores de dose calibrada pressurizada e formulacoes farmaceuticas de aerossol
DK1036062T3 (da) Hydroxamsyrederivater som matrix metalloprotease (MMP) inhibitorer
HUP0105077A3 (en) Serine protease inhibitors and pharmaceutical compositions containing them
ATE293970T1 (de) Lipasehemmer enthaltende pharmazeutische zusammensetzungen
NO982809D0 (no) Prolegemidler av tombin-inhibitorer
NO974069L (no) Orale farmasöytiske doseringsformer omfattende en protonpumpeinhibitor og et NSAID
IL209444A0 (en) O-desmethyl-venlafaxine succinate salts and pharmaceutical compositions containing them
NO20014895D0 (no) Farmasöytisk formulering innbefattende et bisfosfonat og et additivmiddel som gir foröket adsorpsjon av bisfosfonatet
IL128664A (en) Heterocyclic metalloprotease inhibitors and pharmaceutical compositions comprising them
NO20001914D0 (no) <alfa>-Aryl-N-alkylnitroner og farmasøytiske blandinger som inneholder slike
NO20011950L (no) Farmasöytiske blandinger som inneholder poly(ADP-ribose) glukohydrolaseinhibitorer og fremgangsmåter for anvendelse avsamme
HUP0400328A3 (en) Metalloproteinase inhibitor azoles and pharmaceutical compositions containing them
NO20015107L (no) En farmasöytisk formulering som innbefatter en trombininhibitor med lav molekylvekt og dens prodrug
NO20015308D0 (no) En farmasöytisk formulering som inneholder en inhibitor av karboksypeptidase U og A trombininhibitor
HUP0100082A3 (en) Thrombin inhibitor, peptide derivatives, pharmaceutical compositions comprising thereof and their use
NO306114B1 (no) Substituerte 4-fenyltiazolderivater og farmasöytiske blandinger som inneholder dem
NO992998L (no) Nye analoger av camptotecin, anvendelse som medikamenter og farmasöytiske blandinger som inneholder disse
EE200200032A (et) Interleukiin-18 inhibiitorite kasutamine metastaaside pärssimiseks sobivate ravimite valmistamiseksning selliseid inhibiitoreid sisaldav farmatseutiline kompositsioon
NO20013816D0 (no) Benzamidderivater og legemidler som inneholder disse
NO20024354L (no) N-deacetyltiocolchicin-derivater og farmasöytiske sammensetninger inneholdende dem

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application